Letter to the Editor on “Rivaroxaban Use for Thrombosis Prophylaxis is Associated With Early Periprosthetic Joint Infection”
The concern expressed by Brimmo et al[1] regarding the increasing incidence of surgical site infection, as greater efficacy is achieved with deep vein thrombosis prophylaxis, is shared by all experts in the field. Measures of association in a retrospective cohort, as used in their study, would be us...
Autores Principales: | , , , , , |
---|---|
Formato: | Revisión (Review) |
Lenguaje: | Inglés (English) |
Publicado: |
The Journal of Arthroplasty
2016
|
Materias: | |
Acceso en línea: | https://repository.urosario.edu.co/handle/10336/25678 https://doi.org/10.1016/j.arth.2016.05.018 |